SNY News and Press, Sanofi From 01/30/26

2026-01-30 08:51:51 ET More on Sanofi Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi anticipates profitable gro...

2026-01-30 07:07:49 ET More on Regeneron Pharmaceuticals, Sanofi, etc. Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Regeneron: Q4 Earnings Preview - Why I'm Expecting A Beat And Strong 2026 Regeneron P...

2026-01-29 15:22:27 ET Sanofi (SAN:CA) Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Company Participants Thomas Larsen - Head of Investor Relations & General Medicines Paul Hudson - CEO & Director François-Xavier Roger - Executive VP & CFO ...

2026-01-29 13:53:26 ET More on drugmakers Sanofi 2025 Q4 - Results - Earnings Call Presentation Pfizer: A High-Yield Pharma At A Turning Point Novo Nordisk: Investors May Be In For An Earnings Surprise Trump says Eli Lilly to build six “big” U.S...

Nomura Research Institute Ltd. ADR (NRILY) is expected to report $0.33 for Q3 2026 Arthur J. Gallagher & Co. (AJG) is expected to report $2.35 for Q4 2025 STMicroelectronics N.V. (STM) is expected to report $0.27 for Q4 2025 Middlefield Banc Corp. (MBCN) is expected to report $0.6...

2026-01-29 04:09:34 ET More on Sanofi Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript Sanofi (SAN:CA) Disc...

2026-01-29 01:34:26 ET More on Sanofi Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript Sanofi (SAN:CA) Disc...

2026-01-28 11:18:57 ET More on Sanofi Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript Sanofi (SAN:CA) Disc...

2026-01-26 10:55:32 ET More on Moderna, Pfizer Pfizer: Expect Another Double Beating For Q1 (Earnings Preview) Pfizer: Rebound Has Just Started Pfizer: The Most Intriguing Value Play Of 2026 Notable healthcare headlines for the week: J&J, Moderna, Bristol...

2026-01-25 08:07:03 ET As the earnings season gains momentum, the upcoming week is set to deliver one of the most closely watched stretches of earnings season, with heavyweight reporters spanning technology, autos, consumer goods, defense, financials, energy, real estate, and travel. ....